Currently,traditional corneal refractive surgery,such as excimer laser surgery,is the main treatment for myopia.However,corneal refractive surgery requires the removal of a portion of the cor-nea,which limits its application due to the corneal thickness and curvature constraints.In contrast,implant-able collamer lens(ICL)does not require cornea resection,avoiding postoperative corneal ectasia and other complications.In the past,due to limitations in intraocular lens materials,design diversity,and therapeutic concepts,ICL implantation was mainly used for the treatment of high myopia.In recent years,with the de-velopment of novel intraocular lens materials and expanded therapeutic concepts,there has been increasing evidence that ICL implantation has a significant effect in the treatment of low to moderate myopia,compara-ble to conventional laser refractive surgery.Therefore,for individuals who cannot or do not wish to undergo corneal refractive surgery,ICL implantation has become a treatment option that can effectively correct myopia and provide visual experience.(I nt Rev Ophthalmol,2024,48:438-442)
万方数据
